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Abstract: 
There is no known treatment for the dry form of age related macular degeneration (AMD). Cell 
death and inflammation are important biological processes thought to play central role in AMD. 
Here we show that receptor-interacting protein (RIP) kinase mediates necrosis and enhances 
inflammation in a mouse model of retinal degeneration induced by dsRNA, a component of 
drusen in AMD. In contrast to photoreceptor induced apoptosis, subretinal injection of the 
dsRNA analog poly(I:C) caused necrosis of the retinal pigment epithelium (RPE) as well as 
macrophage infiltration into the outer retinas. In Rip3-/- mice, both necrosis and inflammation 
were prevented, providing substantial protection against poly(I:C)-induced retinal degeneration. 
Moreover, after poly(I:C) injection, Rip3-/- mice displayed decreased levels of proinflammatory 
cytokines (such as TNF-α and IL-6) in the retina, and attenuated intravitreal release of high 
mobility group box-1 (HMGB1), a major damage-associated molecular pattern (DAMP). In vitro, 
poly(I:C)-induced necrosis were inhibited in Rip3-deficient RPE cells, which in turn suppressed 
HMGB1 release and dampened TNF-α and IL-6 induction evoked by necrotic supernatants. On 
the other hand, Rip3 deficiency did not modulate directly TNF-α and IL-6 production after 
poly(I:C) stimulation in RPE cells or macrophages. Therefore, programed necrosis is crucial in 
dsRNA-induced retinal degeneration and may promote inflammation by regulating the release of 
intracellular DAMPs, suggesting novel therapeutic targets for diseases such as AMD.
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Introduction: 
Chronic inflammation underlies various neural and retinal degenerative diseases such as 
age-related macular degeneration (AMD), the leading cause of blindness in industrialized 
countries1. AMD is a slowly progressive disease characterized by extracellular deposits formed 
beneath the retinal pigment epithelium (RPE) (called drusen), degeneration of the RPE and 
photoreceptors, the subsequent development of geographic atrophy and/or choroidal 
neovascularization, along with accumulation of inflammatory cells in the macula2, 3. Drusen 
contains several pro-inflammatory components such as complement proteins, lipoproteins, 
oxidized lipids and double-stranded RNA (dsRNA) 4, 5. Moreover, identification of genetic 
variations in inflammation-related genes, such as complement genes, implicates inflammation as 
a potential factor in AMD6. However, the key factors that promote inflammation in AMD and 
the intimate relationship between retinal inflammation and cell death remain elusive. 
Inflammation is an important pathological feature of necrosis7. Damage-associated 
molecular patterns (DAMPs) released from necrotic cells enhance the inflammatory response 
and tissue injury8, 9. Although necrosis was thought to be an uncontrolled process of cell death, it 
is now known to proceed through regulated components in certain instances10. Receptor 
interacting protein 3 (RIP3) is a key mediator of programmed necrosis induced through death 
receptors or toll-like receptors (TLRs)11. During necrosis induction, RIP3 interacts with RIP1 to 
form a pro-necrotic complex, which is stabilized by phosphorylation of their serine/threonine 
kinase domains12, 13, 14. This pathway is critically important in development and in many 
pathological processes15, 16, 17. Notably, Rip3 deficiency not only prevents necrosis but also 
ameliorates inflammation in models of colitis, sepsis, retinal detachment and inherited retinal 
degeneration18, 19, 20, 21. However, the mechanisms by which RIP3 regulates inflammation have 
not been fully explored.  
The dsRNA component of drusen is a ligand for TLR3, which mediates innate immune 
response and cell death. Whereas RIP1 acts as a multifunctional adaptor protein that regulates 
NF-κB-dependent inflammation, apoptosis, and necrosis in TLR3 signaling. RIP3 plays a more 
specific role, which induces necrosis through the formation of the pro-necrotic complex22, 23. 
Although previous studies have shown that intraocular injection of polyinosinic-polycytidylic 
acid [poly(I:C)], a synthetic analog of dsRNA, induces TLR3-dependent retinal degeneration24, 25, 
the downstream molecular and biological events were not elucidated. In this study, we examined 
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the mechanism of cell death of RPE and photoreceptors in dsRNA-induced retinal degeneration 
and identified programed necrosis to promote inflammation by regulating the release of 
intracellular DAMPs and to be crucial in dsRNA-induced retinal degeneration. These findings 
suggest that the RIP kinase-dependent necrotic pathway is a potential target to prevent retinal 
inflammation and degeneration associated with dsRNA accumulation. 
 
Result: 
RIP3-mediated necrosis rather than apoptosis is major mediator of dsRNA-induced retinal 
degeneration in mice. 
To analyze the types of cell death involved in dsRNA-induced retinal degeneration, we 
investigated the morphology of the RPE and photoreceptors by transmission electron microscopy 
(TEM). Two days after poly(I:C) injection, the dying RPE cells exhibited necrotic morphology 
accompanied by swollen cytoplasmic vacuoles in WT mice (Fig. 1A). No apoptotic RPE cells 
with cellular shrinkage or nuclear condensation were observed. On the other hand, the ONL of 
photoreceptors exhibited the presence of both apoptotic and necrotic nuclei after poly(I:C) 
injection (Fig. 1B). The occurrence of photoreceptor necrosis was further supported by the 
finding of swollen vacuoles and disrupted mitochondria in the inner segments (Fig. 1C). In 
contrast features of necrosis in RPE and photoreceptors after poly(I:C) injection were markedly 
notably absent in Rip3-deficient animals (Fig. 1D-F).  
To further examine the role of necrosis in dsRNA-induced retinal degeneration, we 
examined the expression levels of RIP3, which is markedly up-regulated during the induction of 
necrosis in pancreatitis, enteritis, and retinal degeneration13, 20, 21, 26. Subretinal injection of PBS 
did not affect the expression levels of RIP3 compared with untreated retinas in WT mice (Fig. 
S1). In contrast, subretinal injection of poly(I:C) increased retinal RIP3 expression over 5-fold at 
both mRNA and protein levels (P < 0.05, Fig. 2A and B).  
We next evaluated the effect of Rip3 deficiency on poly(I:C)-induced retinal 
degeneration. TUNEL staining, which labels DNA breaks in both necrotic and apoptotic cells, 
showed that poly(I:C) treatment induced a substantial increase in TUNEL-positive cells mainly 
in the outer nuclear layer (ONL) of the WT mouse retinas 2 days after injection (Fig. 2C and D). 
This increase of TUNEL-positive cells was significantly reduced in Rip3-deficient animals (P < 
0.05, Fig. 2C and D).  
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We also assessed the involvement of the caspase-dependent apoptotic pathway in 
poly(I:C)-induced retinal degeneration. Cleavage of caspase-3, a key effector caspase, was 
observed 2 days after poly(I:C) injection; however, the frequency of cleaved caspase-3-positive 
cells was much lower than that of TUNEL-positive cells (Fig. S2). Treatment with the pan-
caspase inhibitor Z-VAD at the time of poly(I:C) injection suppressed caspase-3 cleavage in WT 
mouse retinas (Fig. S2, P < 0.05) but did not sufficiently reduce TUNEL positivity in WT mice 
(Fig. 2C and D). Z-VAD treatment did not provide any additional significant protective effect in 
Rip3-/- mice (Fig. 2C and D). Histological analysis demonstrated severe degeneration of the RPE 
and photoreceptors 14 days after poly(I:C) injection in WT mice (Fig. 2E and F). In contrast, 
there was relative preservation of the structure of the RPE and photoreceptors in Rip3-/- mice (P 
< 0.01, Fig. 2E and F). Immunostaining for zona occludens 1 (ZO-1) confirmed that the loss of 
RPE cells after poly(I:C) injection was attenuated in Rip3-/- mice (P < 0.01, Fig. 2G and H). Z-
VAD treatment, however, did not affect the loss of the photoreceptors or RPE induced by 
poly(I:C) in WT (Fig. 2E and F) or Rip3-/- (Fig. 2G and H) mice. Consistent with the data from 
genetic Rip3 ablation, treatment with the RIP1 kinase inhibitor necrostatin-1 (Nec-1) ameliorated 
poly(I:C)-induced retinal degeneration in WT mice (P < 0.05, Fig. S3). 
Collectively, these data indicate that RIP3-dependent necrosis plays a critical role in 
dsRNA-induced retinal degeneration.  
 
RIP3 promotes a retinal inflammatory response after dsRNA injection in mice.   
We next assessed the effect of subretinal poly(I:C) injection on the inflammatory 
response in Rip3-/- mice. Immunostaining for CD11b demonstrated a robust macrophage 
infiltration around the RPE and in the subretinal space 2 days after poly(I:C) injection in WT 
mice (Fig. 3A and B). In contrast, the macrophage infiltration was significantly reduced in Rip3-/- 
mice (P < 0.01, Fig. 3A and B). Correspondingly, treatment with Nec-1 also suppressed 
macrophage infiltration after poly(I:C) injection (P < 0.05, Fig. S4). In contrast, Z-VAD 
treatment did not affect the recruitment of inflammatory cells induced by poly(I:C) (Fig. S4). We 
also examined the inner retinal inflammation by whole-mount staining for the microglial marker 
Iba-1. In WT mice, the number of microglial cells around the ganglion cell layer was 
substantially increased 2 days after poly(I:C) injection (Fig. S5). In contrast, the microglial 
activation after poly(I:C) treatment was relatively decreased in Rip3-/- mice (P < 0.01, Fig. S5). 
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We next evaluated the expression levels of pro-inflammatory cytokines in mouse retinas 
after poly(I:C) injection. The protein levels of TNF-α and IL-6 were elevated at 6 hours and 
further increased at 48 hours after poly(I:C) injection in WT mice (Fig. 3C and D). Whereas the 
early induction of TNF-α and IL-6 at 6 hours did not differ between Rip3-/- and WT mice, levels 
at 48 hours were substantially decreased in Rip3-/- mice (P < 0.05, Fig. 3C and D).  
Dying or damaged cells release DAMPs that activate immune responses via interaction 
with cellular receptors such as TLRs7. Because high-mobility group box 1(HMGB1) is a major 
DAMP released from necrotic cells27, we examined the changes in HMGB1 release after 
poly(I:C) treatment. Subretinal injection of poly(I:C) induced HMGB1 release into the vitreous 
humor of WT mice at 48 hours after poly(I:C) injection. In contrast, this poly(I:C)-induced 
HMGB1 release was significantly impaired in Rip3-/- mice compared to WT mice (P < 0.01, Fig. 
3E). These findings suggest that RIP3 may regulate the inflammatory responses in dsRNA-
induced retinal degeneration and dampen the release of intracellular DAMPs. 
 
RIP3-dependent necrosis releases DAMP and the necrotic supernatants enhance cytokine 
production from macrophages. 
 We next examined the function of RIP3 in necrosis induction and cytokine production 
using primary RPE cells and macrophages derived from WT or Rip3-/- mice. A previous study 
showed that poly(I:C) combined with a pan-caspase inhibitor causes massive programmed 
necrosis in macrophages28. Consistent with this, RPE cells treated with poly(I:C) and Z-VAD 
showed substantial reduction in cellular viability, which was completely reversed in Rip3-/- RPE 
cells (Fig. 4A). In addition, treatment with poly(I:C) and Z-VAD induced a substantial release of 
HMGB1 from WT RPE cells into the supernatant (Fig. 4B). In contrast, this HMGB1 release 
induced by poly(I:C) and Z-VAD was completely prevented in Rip3-/- RPE cells (Fig. 4B).  
To further analyze the ability of DAMPs to promote inflammation, we incubated 
macrophages with the supernatant from normal or necrotic RPE cells. While the addition of 
supernatants from RPE cells treated with poly(I:C) alone did not increase TNF-α and IL-6 
production in macrophages compared with those from control RPE cells, the supernatant from 
necrotic RPE cells treated with poly(I:C) and Z-VAD substantially increased TNF-α and IL-6 
production (Fig. 4C and D). In contrast, the supernatants from Rip3-deficient RPE cells with 
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either treatment did not enhance cytokine production (Fig. 4C and D), suggesting that DAMPs 
released from necrotic cells are important for the amplification of the inflammatory response.  
 We next investigated whether RIP3 directly modulates NF-κB signaling and cytokine 
production in primary RPE cells and macrophages. Newton et al. previously reported that Rip3-
deficient cells show normal NF-κB signaling in response to TNF-α or lipopolysaccharide (LPS) 
29. Consistent with this report, RPE cells and macrophages derived from either WT or Rip3-/- 
mice exhibited comparable time-dependent phosphorylation of NF-κB after poly(I:C) or TNF-α 
stimulation (Fig. S6 and S7). Furthermore, Rip3-deficient cells produced equivalent levels of 
TNF-α and IL-6 to WT cells after treatment with poly(I:C) or TNF-α (Fig. S6 and S7). These 
findings imply that RIP3 may not directly modulate inflammatory cytokine release induced by 
dsRNA. 
 
Discussion 
In the present study, we demonstrated that RIP3 plays a critical role in inducing necrosis of 
the RPE and photoreceptors as well as sustaining retinal inflammation during dsRNA-induced 
retinal degeneration.  
Our study showed that RPE cells die mainly by necrosis not apoptosis during dsRNA-
induced retinal degeneration. In contrast photoreceptor cell death exhibited both necrotic and 
apoptotic features. Whereas caspase inhibitors had little protective effect in this model, RIPK 
inhibitors, or combined caspase and RIPK inhibitors had significant amelioration of the 
pathology seen. In other models of RPE degeneration such as mice immunized with 
carboxyethylpyrrole-adducted mouse serum albumin and ApoE-/- mice fed with cholesterol-
enriched diet, the RPE cells exhibit vesiculation and swelling rather than pyknosis30, 31, 
consistent with necrotic cell death. Although the cell death pathways in slowly progressive 
human AMD have not been fully characterized, histological studies demonstrated that the 
budding portion of the RPE into the drusen exhibits disintegration and disruption of the plasma 
membrane32. In addition, RPE cells overlying drusen show necrotic changes such as cellular 
enlargement and vacuole formation in early AMD patients33, 34. These findings suggest that 
necrotic pathways may be crucial in RPE cell death in AMD. Interestingly, Yang et al. reported 
that caspase activation is decreased in RPE cells that express low levels of caspase-835. Because 
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catalytic activity of caspase-8 inhibits the formation of the RIP1-RIP3 complex16, the reduced 
caspase-8 expression may predispose RPE cells to undergo necrosis. 
In AMD, rod photoreceptor cells in the parafovea degenerate first before foveal cones die36. 
Shelley et al. reported that the dying cones in AMD patient eyes showed an axonal enlargement 
and swelling37, consistent with necrosis. In addition, in vivo imaging of the fovea in patients with 
geographic atrophy exhibited widening and swelling of foveal structure38, suggesting that 
necrotic signaling may be involved in photoreceptor cell death in AMD, especially in cone cell 
loss. Interestingly, our recent study demonstrated that the secondary cone cell death after rod 
degeneration in a mouse model of retinitis pigmentosa demonstrated necrotic morphology and 
was mediated through RIP kinase21. Although the causes and clinical characteristics of AMD and 
retinitis pigmentosa differ, these findings suggest that the mechanisms underlying the secondary 
cone necrosis may be shared by these diseases. RIP kinase is activated downstream of the 
TNF/Fas family of death ligands as well as dsRNA. Our recent genetic study has identified a 
susceptibility locus for neovascular AMD, which is located 397 bp upstream of the TNF-related 
apoptosis-inducing ligand receptor 139. In addition, Li et al. recently showed that the RIP1-RIP3 
complex forms an amyloid structure, a component of drusen seen in AMD patients40. These 
findings suggest the possible involvement of RIP kinase in AMD pathology, and further studies 
are necessary to clarify the roles of RIP kinase in cell death and inflammation in AMD. 
Reduced inflammatory response in Rip3-/- mice has also been demonstrated in models of 
sepsis, colitis and viral infection12, 18, 19; however, the precise mechanisms by which RIP3 
mediates inflammation remain to be elucidated. Here we showed that Rip3 deficiency suppressed 
the DAMP release from necrotic cells and the cytokine production evoked by necrotic 
byproducts. In contrast, in line with a previous study by Newton et al.29, neither the production of 
TNF-α and IL-6 nor the NF-κB activation in response to poly(I:C) were altered in primary RPE 
cells and macrophages of Rip3-/- mice. Collectively, these findings suggest that RIP3 may not 
directly modulate cytokine production or inflammatory cell function, but rather that RIP3-
induced necrosis of the RPE and photoreceptors enhances retinal inflammation. TLR3 has been 
implicated in various pathological conditions including viral infection, sepsis and retinal 
degeneration8, 25, 41. Although previous studies have mainly focused on a direct pro-inflammatory 
pathway in TLR3 signaling, our data suggest that RIP3-dependent necrotic pathway is also 
important in amplifying tissue inflammation and degeneration in these diseases. 
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Intracellular components such as proteins, nucleotides, and organelles can act as DAMPs 
to stimulate immune response when they are released from dying or dead cells. HMGB1 is one 
of the most characterized DAMPs released from necrotic cells42. It was shown that HMGB-1 
mediates a late-phase inflammatory response and death in septic mice43, 44. Extracellular release 
of HMGB1 is substantially increased during retinal degeneration after retinal detachment 45 as 
well as dsRNA-induced retinal injury. Besides HMGB1, Shichita et al. recently reported that 
other DAMPs such as extracellular peroxiredoxin family proteins mediates post-ischemic 
inflammation in the brain46. In other studies, it was shown that damaged mitochondria released 
from necrotic cells are critical for inflammatory responses to tissue injury47, 48. These findings 
suggest that several DAMPs may contribute to inflammatory amplification in tissue degeneration, 
and that preventing necrosis, which is the source of multiple DAMPs, may be a potential therapy 
to protect tissues against injury and excessive inflammation.  
In conclusion, our data showed that RIP kinase mediates necrosis of the RPE and 
photoreceptors in dsRNA-induced retinal degeneration. Blockade of the RIP kinase pathway 
prevents the DAMP release from dying cells and dampens retinal inflammation, suggesting that 
RIP kinase may be a potential target for retinal degenerative diseases associated with 
inflammation. 
 
 
Materials and Methods 
Animals  
All animal experiments adhered to the statement of the Association for Research in Vision and 
Ophthalmology, and protocols were approved by the Animal Care Committee of Massachusetts 
Eye and Ear Infirmary. Rip3-/- mice were provided by Dr. Vishva M. Dixit (Genentech, San 
Francisco, CA) and backcrossed to C57BL/6 mice29. Age-matched WT C57BL/6 mice were 
purchased from The Jackson Laboratories (Bar Harbor, ME). Mice were fed standard laboratory 
chow and allowed free access to water in an air-conditioned room with a 12 hour light/12 hour 
dark cycle. 
 
Subretinal injection  
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Mice were anesthetized by intraperitoneal injection of 100 mg/kg ketamine and 10 mg/kg 
xylazine. Pupils were dilated and a sclerotomy was created approximately 1 mm posterior to the 
limbus in the nasal hemisphere with a 30-gauge needle. A Glaser subretinal injector (20-gauge 
shaft with a 32-gauge tip; BD Biosciences, San Diego, CA) connected to a syringe filled with 
poly(I:C) solution (1 mg/ml in PBS; Enzo, Farmingdale, NY) was introduced into the subretinal 
space, and 2 µl of solution was injected. Successful administration was confirmed by the creation 
of retinal detachment of approximately one half of the retina. As a control, PBS was injected by 
the same procedure. For treatment with inhibitors or antagonists, poly(I:C) solution was mixed 
with Z-VAD (Enzo), Nec-1 (Sigma, Saint Louis, MI) or Box A (HMGBiotech, Milano, Italy) 
with the final concentration of 300 µM, 400 µM and 10 µg/ml, respectively. The doses of the 
compounds and recombinants were selected based on previous reports20, 49. Eyes that sustained 
marked surgical trauma (e.g., retinal or subretinal hemorrhage, bacterial infection) were excluded 
from further analyses.  
 
Cell culture 
RPE cells were prepared as previously described with minor modifications50. The RPE-choroid-
sclera complex of C57BL/6 or age-matched Rip3-/- mice was separated and incubated in 0.2% 
Trypsin (Life Technologies) for 1 hour at 37°C in a 5% CO2 atmosphere. The eyecups were 
transferred to DMEM medium (Life Technologies), and RPE sheets were scraped off with a 
forceps. The RPE sheets were triturated to form a single cell suspension, resuspended in DMEM 
medium containing 10% FBS (Life Technologies), and seeded into 35 mm dishes. The RPE cells 
between passages 3 to 6 were plated into 96- or 12 wells at 2 x 104 cells/cm2 and were used for 
experiments.  
 Peritoneal macrophages were obtained from C57BL/6 or age-matched Rip3-/- mice 3 days 
after intraperitoneal injection of 3 ml 4% thioglycollate (BD biosciences) as previously 
described51. The cells collected from the peritoneal cavity were resuspended in RPMI medium 
(Life Technologies) containing 10% FBS, and seeded into 12 wells at 1 x 105 cells/cm2. Plates 
were washed twice, 6 hours after seeding, and adherent macrophages were used directly for the 
experiments.   
 
Viability assay  
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Twenty four hours after poly(I:C) (5 µg/ml) or TNF-α (30 ng/ml; R&D systems) stimulation, the 
cell viability was assessed by a modified MTT assay (Cell Counting Kit-8; Dojindo Laboratories, 
Kumamoto, Japan). Treatment with Z-VAD (30 µM) or Nec-1 (30 µM) was performed 1 hour 
before poly(I:C) or TNF-α stimulation. This assay is based on the cleavage of 2-(2-methoxy-4-
nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt (WST-8) 
to formazan dye by the mitochondrial dehydrogenase enzyme. After incubation with WST-8 for 
2 hours at 37°C, the absorbance was measured at 450 nm using a microplate leader.  
 
Stimulation of macrophages with the supernatants from RPE cells 
WT or Rip3-/- RPE cells were treated with PBS, poly(I:C) (5 µg/ml), or poly(I:C) plus Z-VAD 
(30 µM). Three hours after stimulation, the culture medium was washed three times to remove 
poly(I:C) and replaced by fresh medium. After incubation for 24 hours, the cellular supernatants 
were added to untreated WT macrophages. The amount of pro-inflammatory cytokines in the 
macrophage culture medium was measured by ELISA 24 hours after treatment with the RPE 
supernatants.  
  
RNA Extraction, RT-PCR, and Quantitative Real-Time PCR  
The posterior eyecups of mice containing the neuroretina, RPE/choroid and sclera were minced 
with scissors in lysis buffer (QIAGEN, Valencia, CA). Total RNA extraction and reverse 
transcription were performed as previously reported20. A real-time PCR assay was performed 
with Prism 7700 Sequence Detection System (Applied Biosystems, Foster City, CA). TaqMan 
Gene Expression assays were used to check the expression of RIP3 (Mm00444947_m1). For 
relative comparison of each gene, we analyzed the Ct value of real-time PCR data with the ǻǻCt 
method normalizing by an endogenous control (β-actin; Mm00607939_s1).  
 
Western Blotting 
The posterior eyecups of mice or cells were collected and lysed in lysis buffer [50 mM Tris-HCl 
(pH 8), 120 mM NaCl and 1% NP-40, supplemented with a mixture of protein inhibitors (Roche 
Diagnostics, Basel, Switzerland)]. Samples were run on 4-12% SDS-polyacrylamide gel 
electrophoresis and transferred onto PVDF membrane. After blocking with blocking buffer 
(Thermo Scientific, Rockford, IL), the membrane was reacted with RIP3 (1:10000; Sigma, Saint 
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Louis, MI) or p-NF-κB (1:1000; Cell signaling, Danvers, MA) antibody. Membranes were then 
developed with enhanced chemiluminescence. Lane-loading differences were normalized by £-
actin (1:1000; Cell signaling).  
 
Histological Examination 
Mouse eyes were enucleated and frozen in OCT compound (Sakura Finetechnical Co., Tokyo, 
Japan). Sections (ңҢ µm thick) were prepared along the horizontal meridian and subsequently 
stained with hematoxylin and eosin. Five sections were randomly selected from each eye. The 
mid-peripheral retina in the poly(I:C)-injected area (800 µm from the optic nerve in the nasal 
hemisphere) was photographed, and the ONL thickness were measured at 10 points in each 
section and averaged. The tissue samples were assigned numbers and letters, and the observers 
were masked from the conditions. 

TUNEL Staining 
TUNEL procedure and quantification of TUNEL-positive cells were performed using an 
ApopTag Fluorescein Direct In Situ Apoptosis Detection Kit (Millipore, Billerica, MA) 
according to the instructions of the manufacturer. Five sections were randomly selected in each 
eye. The mid-peripheral retina in poly(I:C)-injected areas (800 µm from the optic nerve in the 
nasal hemisphere) was photographed, and the number of TUNEL-positive cells in the ONL was 
counted by masked observers. The retinal area was measured by ImageJ 1.43u software. The 
data are expressed as TUNEL-positive cells/mm2 of retinal area.  

Flatmount staining 
Eyes were enucleated and fixed in 4% PFA for 1 hour. After washing with PBS, the anterior 
segment and the neuroretina were removed under a microscope. The RPE-choroid-sclera 
complex was blocked with 10% nonfat dried milk and 0.3% triton X in PBS for 1 hour, and was 
incubated with Alexa Fluor 594-conjugated Zo-1 antibody (1:100; Life Technologies, Grand 
Island, NY) at 4°C overnight. Five areas in poly(I:C)-injected areas were randomly photographed 
at x40 magnification with a Leica SP2 confocal microscopy, and the number of RPE cells were 
counted using ImageJ 1.43u software and averaged. 
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Immunofluorescence
Cryosections were incubated with anti-CD11b antibody (1:100; BD biosciences) or anti-cleaved 
caspase-3 (1:100; Cell signaling) at 4°C overnight. A nonimmune serum was used as a negative 
control. Alexa Fluor 594-conjugated antibodies (1:300; Life Technologies) were used as 
secondary antibodies. Immunofluorescence images were acquired with a Leica SP2 confocal 
microscopy.  
 
ELISA 
The protein levels of TNF-α and IL-6 in the extracts from posterior eyecups were determined 
with ELISA kits for TNF-α (R&D systems, Minneapolis, MN) and IL-6 (R&D systems). For 
HMGB1 measurement, the mouse posterior eyecups were put into 100 µl PBS in a 96 well plate, 
and then the vitreous humor was collected. Samples were centrifuged at 15,000 rpm for 5 min, 
and the supernatants were subjected to HMGB1 ELISA (Shinotest Corporation, Tokyo, Japan) 
according to the manufacturer’s instructions.  

TEM  
The eyes were enucleated, and the posterior segments were fixed in 2.5% glutaraldehyde and 2% 
paraformaldehyde in 0.1 M cacodylate buffer with 0.08 M CaCl2 at 4°C. The sections of 
posterior eyecups were postfixed for 1.5 hours in 2% aqueous OsO4, dehydrated in ethanol and 
water, and embedded in EPON. Ultrathin sections were cut from blocks and stained with 
saturated aqueous uranyl acetate and Sato’s lead stain. The specimens were observed with 
Philips CM10 electron microscope.  
 
Statistical Analysis. 
Statistical differences between two groups were analyzed by Mann-Whitney U test. Multiple 
group comparison was performed by ANOVA followed by Tukey-Kramer adjustments. 
Differences were considered significant at P < 0.05. 
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Figure Legends 
Figure 1. RIP3 mediates necrosis of the RPE and photoreceptors after dsRNA injection in 
mice. 
(A-F) TEM photomicrographs in the RPE (A and D) and the ONL (B and E) and IS (C and F) of 
photoreceptors in the WT (A-C) or Rip3-/- (D-F) retinas 2 days after subretinal poly(I:C) 
injection. Necrotic cell death of photoreceptors and RPE cells induced by poly(I:C) was 
substantially prevented in Rip3-/- mice. A: Apoptotic cell, N: Necrotic cell. Scale bar, 5 µm (A, B, 
D and E), 2 µm (C and F). 
 
Figure 2. RIP3 mediates photoreceptor and RPE cell loss induced by dsRNA in mice. 
(A) Quantitative real-time PCR analysis for RIP3 in the retina 2 days after subretinal injection of 
PBS or poly(I:C) (n = 4 each). *, P < 0.05. 
(B) Western blot analysis for RIP3 in the retina 2 days after subretinal injection of PBS or 
poly(I:C) (n = 4 each). Levels normalized to β-actin. The bar graphs indicate the relative level of 
RIP3 to β-actin by densitometric analysis. *, P < 0.05. 
(C and D) TUNEL (green) and DAPI (blue) staining (C) and quantification of TUNEL-positive 
cells (D) in WT or Rip3-/- retinas 2 days after subretinal injection of PBS (n = 6 each), poly(I:C) 
(n = 6 in WT and n = 7 in Rip3-/-), or poly(I:C) plus Z-VAD (n = 7 each). Subretinal poly(I:C) 
injection induced TUNEL-positive cells mainly in the ONL in WT mice. This increase of 
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TUNEL-positive cells was reduced by Rip3 deficiency, but not by the pan-caspase inhibitor Z-
VAD. GCL: ganglion cell layer, INL: inner nuclear layer. Scale bar, 50 µm. *, P < 0.05 vs. WT 
eyes treated with poly(I:C).  
(E and F) Retinal histology (E) and quantification of ONL thickness (F) in the WT or Rip3-/- 
retinas 14 days after subretinal injection of PBS (n = 5 each), poly(I:C) (n = 5 each), or poly(I:C) 
plus Z-VAD (n = 7 in WT and n = 6 in Rip3-/-). Rip3 deficiency prevented the degeneration of 
photoreceptors and RPE after poly(I:C) injection. Scale bar, 50 µm. **, P < 0.01 vs. WT eyes 
treated with poly(I:C).  
(G and H) ZO-1 staining (G) and quantification of ZO-1-positive RPE cells (H) in the WT or 
Rip3-/- choroidal flatmounts 14 days after subretinal injection of PBS (n = 4 each), poly(I:C) (n = 
6 each), or poly(I:C) plus Z-VAD (n = 6 each). The loss of RPE cells after poly(I:C) injection 
was attenuated in Rip3-/- mice. Scale bar, 50 µm. **, P < 0.01 vs. WT eyes treated with poly(I:C).  
(A, B, D, F and H) The graphs show mean ± SEM.  
 
Figure 3. RIP3 promotes retinal inflammatory response in dsRNA-induced retinal 
degeneration in mice. 
(A and B) Immunofluorescence for CD11b (A) and quantification of CD11b-positive cells (B) in 
WT or Rip3-/- retinas 2 days after subretinal poly(I:C) injection (n = 8 each). Infiltration of 
CD11b-positive cells into the outer retina was substantially decreased in Rip3-/- mice. Scale bar, 
50 µm. **, P < 0.01. 
(C and D) ELISA to detect TNF-α (C) and IL-6 (D) in the WT or Rip3-/- retinas before (n = 4 
each) and 6 hours (n = 5 each) and 2 days (n = 8 in WT and n = 7 in Rip3-/-) after poly(I:C) 
injection. TNF-α and IL-6 generation 2 days after injection was suppressed in Rip3-/- mice. *, P 
< 0.05.  
(E) ELISA for HMGB1 in the vitreous humor of WT or Rip3-/- mice before (n = 4 each) and 2 
days (n = 7 in WT and n = 8 in Rip3-/-) after poly(I:C) injection. Intravitreal release of HMGB1 
was decreased in Rip3-/- mice. **, P < 0.01.  
(B-E) The graphs show mean ± SEM.  
 
Figure 4. RIP3-dependent necrosis releases HMGB1 and the necrotic supernatants enhance 
cytokine production from macrophages 
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(A) Cell viability assay in RPE cells 24 hours after treatment with vehicle, Z-VAD (30 µM), 
poly(I:C) (5 µg/ml), poly(I:C) plus Z-VAD, TNF-α (30 ng/ml), or TNF-α plus Z-VAD (n = 4 
each). The reduction in cellular viability by poly(I:C) plus Z-VAD or TNF-α plus Z-VAD was 
inhibited in Rip3-deficient cells. *, P < 0.01 vs. controls. ̐, P < 0.01, vs. WT cells. 
(B) ELISA for HMGB1 in the supernatant of RPE cells 24 hours after treatment with vehicle, 
poly(I:C), or poly(I:C) plus Z-VAD (n = 4 each). HMGB1 release by poly(I:C) plus Z-VAD was 
prevented in Rip3-deficient cells. *, P < 0.01 vs. controls. ̐, P < 0.01, vs. WT cells.  
(C and D) ELISA for TNF-α (C) and IL-6 (D) in macrophages treated with necrotic supernatants. 
WT or Rip3-/- RPE cells were treated with vehicle, poly(I:C), or poly(I:C) plus Z-VAD, and 3 
hours after stimulation, the culture medium was washed and replaced by fresh medium. After 24 
hours incubation, the cellular supernatant from RPE cells was applied to macrophages (n = 4 
each). The supernatant from necrotic WT RPE cells treated with poly(I:C) plus Z-VAD increased 
TNF-α and IL-6 generation from macrophages. In contrast, in Rip3- deficient cells, TNF-α and 
IL-6 did not increase. *, P < 0.01 vs. controls. ̐, P < 0.01, vs. WT cells. 
(A-D) The graphs show mean ± SD.  
 
 
 
 




